Life Science Investing Aytu BioPharma Announces Commercial Availability of EXXUA Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults
Life Science Investing Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference
Life Science Investing Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results
Homerun Resources Inc. Announces Advancement of Road Improvements Servicing Santa Maria Eterna Silica and Solar Glass Hub
